News
Zacks Investment Research on MSN2h
Septerna Stock Surges on Oral Obesity Drug Deal With Novo NordiskShares of Septerna SEPN surged 51% on May 14 after the company entered into an exclusive global collaboration and license ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback